This is Nottingham One of the side effects of this drug, dexamethasone , the inquest was told, was that it could lead patients to have disturbing thoughts. Another nurs...
OncLive As chairman of the Myeloma Committee within the cooperative SWOG (formerly the Southwest Oncology Group), he is principal investigator for SO777, a phase III, 600-patient trial comparing lenalidomide plus dexamethasone against the two drugs in ...
This is Leicestershire The inquest was told one of the side effects of the drug dexamethasone was that it could lead patients to have disturbing thoughts. Nurse Rowena Pulk also gave evidence yesterday, on the first day of the four-day hearing in Nottingham. She said in the ...
The Myeloma Beacon Referring to a study about quisinostat and another study of the related drug panobinostat, Dr. van Rhee said, “The histone deacetylase inhibitors panobinostat and quisinostat when combined with Velcade and dexamethasone [Decadron] were reported to ...
The Myeloma Beacon Currently, I have had a very good response from 3 cycles of the “CYCLONE” regimen: Kyprolis (carfilzomib), cyclophosphamide (Cytoxan), thalidomide (Thalomid), and dexamethasone (Decadron). The lesions that had shown up on my PET scan have ...
Boston Business Journal (blog) Last week, Ocular said it completed enrollment for its sustained release dexamethasone (OTX-DP) in a Phase 2 study under an Investigational New Drug (IND) submission to the U.S. Food and Drug Administration. The trial will study the safety and efficacy ... and more »
Healio Ocular Therapeutix Inc. announced it has completed enrollment for its sustained release dexamethasone in a phase 2 study under an Investigational New Drug submission to the U.S. Food and Drug Administration, according to a company press release.
